Ind-Swift Laboratories (NSE:INDSWFTLAB) Total Equity : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Total Equity?

Ind-Swift Laboratories's total equity for the quarter that ended in Dec. 2023 was ₹0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ind-Swift Laboratories Total Equity Historical Data

The historical data trend for Ind-Swift Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Total Equity Chart

Ind-Swift Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Equity

Get a 7-Day Free Trial

5,878.14

6,406.36

6,034.16

6,008.62

6,819.31

Ind-Swift Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															-	6,819.31	-	7,303.16	-

Ind-Swift Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ind-Swift Laboratories's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2023 )	-	Total Liabilities(Q: Mar. 2023 )
	=	18240.64	-	11421.333
	=	6,819

Ind-Swift Laboratories's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	N/A	-	N/A
	=	N/A

Ind-Swift Laboratories Total Equity Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Total Equity

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines